• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About
  • BCPS
  • Medicine and Media
  • Pharmacogenomics
  • Podcast
Digital PharmD

Digital PharmD

Informatics in Pharmacy

Headache

August 13, 2018 By Dr. G, PharmD

Print Friendly, PDF & Email

Acute:

  • Treat with NSAIDS, APAP, 5-HT receptor antagonists (triptans).
  • Prophylaxis: Avoid precipitants, TCAs, propranolol, topiramate, verapamil, valproic acid, NSAIDs, Botox, Magnesium, Vitamin B12, CoQ10, feverfew

Migraine:

  • If they are recurrent, interfere with daily activities or patient prefers prophylactic therapy, prophylaxis should be considered. Use lowest effective dose, give 2 – 3-month trial, consider a choice that also helps with comorbidity
  • Possibilities: Frovatriptan for menstrual migraines, metoprolol (not in asthma, but may help in HTN), Botox, petasites/butterbur, propranolol, timolol, topiramate, valproic acid
  • Triptans are good for an acute migraine.
  • Butorphanol has an intranasal route, good for nausea and vomiting

Tension Headaches:

Treatment: APAP, NSAID, ASA, treat depression and anxiety
Prophylaxis: Tricylic antidepressants, Botox

Cluster Headaches:

Treatment: triptans, oxygen, intranasal lidocaine, octreotide and 10% cocaine
Prophylaxis: verapamil, melatonin, suboccipital injection of betametasone, lithium (~0. 3 mmol/L, subtherapeutic, dose for bipolar = 0.8 – 12)

Filed Under: Neurology

Primary Sidebar

Newsletter

More to See

COVID-19 mRNA EUA Vaccine FAQs

December 29, 2020 By Dr. G, PharmD

What Makes a Good Vaccine? (Part 1)

October 20, 2020 By Dr. G, PharmD

Tags

acid base acidosis acute coronary syndrome alkalosis analgesics anaphylaxis aortic dissection arrhythmia bcps Beta-Blockers biostatistics blood pressure cardiac markers CHA2DS2-VasC cocaine COVID-19 diabetes diabetes inspidius heart failure Heparin hypersensitivity hypertension hypovolemic shock intubation ionotropes journal club lipids LMWH medication safety morphine conversions myocardial infarction needs work NOAC NSTEMI obstructive shock pharmacoeconomics pheochromocytoma pressors reference materials right mi sedation septic shock shock STEMI Updated 2020

Footer

Medical Disclaimer

The medical information on this website is provided “as is” without any representations or warranties, express or implied. GoPharmD makes no representations or warranties in relation to the medical information on this website.

GoPharmD does not warrant that:

  • the medical information on this website will be constantly available, or available at all; or
  • the medical information on this website is complete, true, accurate, up-to-date, or non-misleading.
  • You must not rely on the information on this website as an alternative to medical advice from your doctor or other professional healthcare provider.
  • If you have any specific questions about any medical matter you should consult your doctor or other professional healthcare provider.

Recent

  • Johnson and Johnson Coronavirus EUA Vaccine FAQ
  • COVID-19 mRNA EUA Vaccine FAQs
  • What Makes a Good Vaccine? (Part 1)
  • COPD and Bronchitis
  • Asthma

Search

Tags

acid base acidosis acute coronary syndrome alkalosis analgesics anaphylaxis aortic dissection arrhythmia bcps Beta-Blockers biostatistics blood pressure cardiac markers CHA2DS2-VasC cocaine COVID-19 diabetes diabetes inspidius heart failure Heparin hypersensitivity hypertension hypovolemic shock intubation ionotropes journal club lipids LMWH medication safety morphine conversions myocardial infarction needs work NOAC NSTEMI obstructive shock pharmacoeconomics pheochromocytoma pressors reference materials right mi sedation septic shock shock STEMI Updated 2020